患者在外侧面部黑色素瘤手术治疗中将局部复发风险置于其他属性之上:一项陈述性偏好调查与基于选择的联合分析结果
研究通过陈述性偏好调查和基于选择的联合分析评估患者对面部黑色素瘤手术治疗的偏好。94.3%的患者将局部复发风险评为非常重要并列为最重要属性,超过73%的受访者首选莫氏显微手术联合免疫染色或慢速莫氏手术。数据来自单一医疗系统。
要点
- 94.3%的患者将局部复发风险评为非常重要,并列为面部黑色素瘤手术治疗的最重要属性。
- 联合分析显示属性重要性从高到低依次为:局部复发率、自付费用、二次手术就诊几率、重建时机、旅行时间、手术室内时间。
- 超过73%的受访者首选莫氏显微手术联合免疫染色或慢速莫氏手术作为面部黑色素瘤的治疗选择。
核心结论
- 患者偏好能最小化局部复发风险的手术治疗选项,旅行和治疗的后勤安排对患者偏好的影响较小。
- 大多数调查参与者选择莫氏显微手术联合免疫染色以最大化局部治愈和护理便利性。
研究设计与样本
- 研究包括两部分:陈述性偏好调查和基于选择的联合分析实验,参与者为患者。
主要发现
- 94.3%的患者将局部复发风险评为非常重要,并列为面部黑色素瘤手术治疗的最重要属性。
- 通过基于选择的联合分析,患者对手术属性的重要性排序从高到低为:局部复发率、自付费用、二次手术就诊几率、重建时机、旅行时间、手术室内时间。
- 超过73%的受访者选择莫氏显微手术联合免疫染色或慢速莫氏手术作为面部黑色素瘤的首选治疗选项。
局限性
- 数据来自单一医疗系统。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical treatment options for facial melanomas include conventional excision with postoperative margin assessment, Mohs micrographic surgery (MMS) with immunostains (MMS-I), and slow MMS. Patient preferences for these surgical options have not been studied. OBJECTIVES: To evaluate patient preferences for surgical treatment of facial melanoma and to determine how patients value the relative importance of different surgical attributes. METHODS: Participants completed a 2-part study consisting of a stated preference survey and a choice-based conjoint analysis experiment. RESULTS: Patients overwhelmingly (94.3%) rated local recurrence risk as very important and ranked it as the most important attribute of surgical treatment for facial melanoma. Via choice-based conjoint analysis, patients ranked the following surgical attributes from highest to lowest in importance: local recurrence rate, out-of-pocket cost, chance of second surgical visit, timing of reconstruction, travel time, and time in office for the procedure. Consistent with their prioritization of low local recurrence rates, more than 73% of respondents selected MMS-I or slow MMS as their preferred treatment option for a facial melanoma. LIMITATIONS: Data were obtained from a single health system. CONCLUSION: Patients prefer surgical treatment options that minimize risk for local recurrence. Logistics for travel and treatment have less influence on patient preferences. Most survey participants chose MMS-I to maximize local cure and convenience of care.
引用
- Etzkorn JR, Tuttle SD, Lim I, et al. Patients prioritize local recurrence risk over other attributes for surgical treatment of facial melanomas-Results of a stated preference survey and choice-based conjoint analysis. J Am Acad Dermatol. 2018. PMID: 29505861. doi:10.1016/j.jaad.2018.02.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。